Metropolitan Life Insurance CO Senseonics Holdings, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.68 - $1.25 $1,270 - $2,336	-1,869 Reduced 6.76%	25,787 $18,000
Q4 2022 Jun 14, 2023	BUY	$0.96 - $1.34 $1,794 - $2,504	1,869 Added 7.25%	27,656 $28.5 Million
Q3 2022 Jun 14, 2023	BUY	$1.02 - $2.23 $1,906 - $4,167	1,869 Added 7.25%	27,656 $36.5 Million
Q3 2022 Mar 30, 2023	BUY	$1.02 - $2.23 $10,750 - $23,504	10,540 Added 61.58%	27,656 $36,000
Q3 2022 Nov 14, 2022	BUY	$1.02 - $2.23 $10,750 - $23,504	10,540 Added 61.58%	27,656 $37,000
Q2 2022 Jun 20, 2023	SELL	$0.94 - $1.94 $8,150 - $16,821	-8,671 Reduced 33.63%	17,116 $17,000
Q2 2022 Mar 30, 2023	SELL	$0.94 - $1.94 $10,084 - $20,812	-10,728 Reduced 38.53%	17,116 $17,000
Q2 2022 Aug 11, 2022	SELL	$0.94 - $1.94 $10,084 - $20,812	-10,728 Reduced 38.53%	17,116 $18,000
Q1 2022 Jun 20, 2023	BUY	$1.54 - $3.71 $3,167 - $7,631	2,057 Added 7.98%	27,844 $54,000
Q1 2022 Mar 30, 2023	SELL	$1.54 - $3.71 $107,373 - $258,672	-69,723 Reduced 71.46%	27,844 $54,000
Q1 2022 May 12, 2022	SELL	$1.54 - $3.71 $107,373 - $258,672	-69,723 Reduced 71.46%	27,844 $55,000
Q4 2021 Jun 21, 2023	BUY	$2.58 - $3.91 $185,192 - $280,659	71,780 Added 278.36%	97,567 $260,000
Q4 2021 Mar 30, 2023	SELL	$2.58 - $3.91 $7,605 - $11,526	-2,948 Reduced 2.93%	97,567 $260,000
Q4 2021 Feb 15, 2022	SELL	$2.58 - $3.91 $7,605 - $11,526	-2,948 Reduced 2.93%	97,567 $261,000
Q3 2021 Jun 21, 2023	BUY	$2.77 - $4.05 $206,996 - $302,648	74,728 Added 289.79%	100,515 $340,000
Q3 2021 Mar 30, 2023	SELL	$2.77 - $4.05 $45,051 - $65,869	-16,264 Reduced 13.93%	100,515 $340,000
Q3 2021 Nov 15, 2021	SELL	$2.77 - $4.05 $45,051 - $65,869	-16,264 Reduced 13.93%	100,515 $341,000
Q2 2021 Jun 21, 2023	BUY	$1.71 - $4.14 $155,596 - $376,706	90,992 Added 352.86%	116,779 $448,000
Q2 2021 Mar 30, 2023	BUY	$1.71 - $4.14 $154,595 - $374,284	90,407 Added 342.81%	116,779 $448,000
Q2 2021 Aug 16, 2021	BUY	$1.71 - $4.14 $199,692 - $483,465	116,779 New	116,779 $448,000
Q2 2019 Jul 12, 2023	BUY	$1.81 - $2.45 $1,058 - $1,433	585 Added 2.27%	26,372 $53.8 Million
Q2 2019 Aug 14, 2019	SELL	$1.81 - $2.45 $47,733 - $64,611	-26,372 Closed	0 $0
Q1 2019 Jul 13, 2023	BUY	$2.3 - $3.27 $1,345 - $1,912	585 Added 2.27%	26,372 $64,000
Q1 2019 Mar 30, 2023	SELL	$2.3 - $3.27 $2,953 - $4,198	-1,284 Reduced 4.64%	26,372 $64,000
Q1 2019 May 16, 2019	BUY	$2.3 - $3.27 $27,770 - $39,481	12,074 Added 84.45%	26,372 $64,000
Q1 2019 May 15, 2019	SELL	$2.3 - $3.27 $22,956 - $32,637	-9,981 Reduced 41.11%	14,298 $2.19 Million
Q4 2018 Jul 13, 2023	SELL	$2.49 - $4.54 $3,754 - $6,846	-1,508 Reduced 5.85%	24,279 $62,000
Q4 2018 Feb 14, 2019	BUY	$2.49 - $4.54 $47,215 - $86,087	18,962 Added 356.63%	24,279 $63,000
Q3 2018 Jul 13, 2023	SELL	$3.4 - $4.84 $5,127 - $7,298	-1,508 Reduced 5.85%	24,279 $116 Million
Q3 2018 Nov 14, 2018	SELL	$3.4 - $4.84 $64,470 - $91,776	-18,962 Reduced 78.1%	5,317 $25,000
Q2 2018 Aug 15, 2018	BUY	$3.03 - $4.98 $73,565 - $120,909	24,279 New	24,279 $0

Others Institutions Holding SENS

# of Institutions

140

Shares Held

59.9M

Call Options Held

393K

Put Options Held

254K

Vanguard Group Inc Valley Forge, PA

23.5M
Shares

$18.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.32M
Shares

$6.49 Million
0.0% of portfolio
Masters Capital Management LLC Atlanta, GA

7M
Shares

$5.46 Million
0.12% of portfolio
Geode Capital Management, LLC Boston, MA

5.84M
Shares

$4.55 Million
0.0% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

3.06M
Shares

$2.39 Million
0.0% of portfolio

View Full List

About Senseonics Holdings, Inc.

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $363M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

More about SENS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account